Oros Pharmaceuticals Private Limited
About Oros Pharmaceuticals Private Limited
Data last updated:
Oros Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 01 October 2009.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2009PTC065273.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Saisha Pharmaceuticals Private Limited. It was led by directors Srinivasa Rao Vankayalapati (Whole-Time Director) and Komala Devi Vankayalapati.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Flat No: 201 3 – 5 – 83/7 Virupas Mithila Apartment Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Company details
CIN history
Oros Pharmaceuticals has one previous CIN (Corporate Identification Number): U73100AP2009PTC065273. The current CIN is U73100TG2009PTC065273, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2009PTC065273 | Current |
| U73100AP2009PTC065273 | Previous |
Contact details
Oros Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No: 201 3 – 5 – 83/7 Virupas Mithila Apartment Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Oros Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oros Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Oros Pharmaceuticals Private Limited, buy the company report.
Financials of Oros Pharmaceuticals Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oros Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oros Pharmaceuticals Private Limited
Oros Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komala Devi Vankayalapati Also directs: Arrien-Rajendra Spinning Mills Private Limited, New Line Medicines Private Limited, Rxbridge Pharma Private Limited and 1 more | Director | 05 Jan 2022 | 4 Years 9 Months | As last reported |
| Srinivasa Rao Vankayalapati Also directs: Arrien-Rajendra Spinning Mills Private Limited, New Line Medicines Private Limited, Rxbridge Pharma Private Limited and 1 more | Whole-Time Director | 20 Dec 2010 | 15 Years 10 Months | As last reported |
Auditor
Oros Pharmaceuticals Private Limited is audited by D SIVA NAGESWARA RAO & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D SIVA NAGESWARA RAO & CO | FY 2020 | 007162S |
Shareholding
The shareholding of Oros Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Oros Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oros Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oros Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Oros Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Oros Pharmaceuticals Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Appalaneni Rajendra Prasad ceased to be Director on 06 Jan 2022.
Frequently asked questions
Oros Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Oros Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 01 October 2009 and is registered under CIN U73100TG2009PTC065273. The company has been struck off by the Registrar of Companies and is no longer operational.
Oros Pharmaceuticals had 2 directors:
- Srinivasa Rao Vankayalapati - Whole-Time Director
- Komala Devi Vankayalapati - Director
The CIN (Corporate Identification Number) of Oros Pharmaceuticals is U73100TG2009PTC065273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Oros Pharmaceuticals is at Flat No: 201 3 – 5 – 837 Virupas Mithila Apartment Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Oros Pharmaceuticals was incorporated on 01 October 2009. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Oros Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
Oros Pharmaceuticals operated in the pharma industry, in the pharma contract r and d segment. It worked in this industry before it was struck off.
Appalaneni Rajendra Prasad ceased to be Director on 06 Jan 2022. Komala Devi Vankayalapati was appointed as Director on 05 Jan 2022. Vankayalapati Sridevi ceased to be Director on 05 Apr 2019. Oros Pharmaceuticals has 8 board changes on record in total.
The compliance status of Oros Pharmaceuticals is compliant as of 10 September 2026.